The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Advair HFA 115-21 MCG inhalers. The $12,577.37 contract has a period of performance through March 22, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. This award is associated with a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Advair HFA 230-21 MCG Inhaler 12GM medication. The $3,975.72 contract has a performance period through March 26, 2024 and does not have a set-aside designation. AmerisourceBergen Drug Corp is the prime contractor on this delivery order, which is placed against a $999,999,999.00 indefinite delivery contract (IDC)...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply Advair HFA 230-21 mcg inhalers. The contract has a completion date of February 27, 2024 and a potential value of $3,975.72. Amerisourcebergen Drug Corp is the prime contractor and does not have any major subcontractors listed. This delivery order contract is issued under a larger indefinite delivery contract (IDC) with...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,862.36 to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The contract is for the delivery of Advair HFA 230-21 MCG inhalers to support military treatment programs and facilities. The delivery order was issued under an existing indefinite delivery contract (IDC) between DLA and AmerisourceBergen Drug Corp, which has a...
The U.S. Defense Logistics Agency Troop Support Medical has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Advair HFA 230-21 mcg inhaler 12 gm. The contract has a potential value of $1,325.24 and a period of performance through February 14, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a maximum potential value of...
The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract worth $1,042.55 for the supply of Advair HFA 230-21 mcg inhalers. The contract has a period of performance through March 1, 2024 and does not include any set-aside designations. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is issued under a larger $999,999,999.00 indefinite delivery contract (IDC)...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Advair HFA 115-21 mcg inhalers. The $16,859.04 contract has a completion date of February 22, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor and serves as the primary supplier of pharmaceuticals and medical supplies to DLA Troop Support Medical facilities...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Advair HFA 45-21 mcg inhalers. The $2,706.60 contract has an ultimate completion date of April 1, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of Advair HFA 115-21 MCG Inhaler 8GM. The contract has a ceiling value of $1,786.52 and an ultimate completion date of April 12, 2024. AmerisourceBergen Drug Corp is also the prime contractor on an indefinite delivery contract (IDC) awarded by DLA with a potential value of $999,999,999.00 and a performance...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Advair HFA 230-21 MCG Inhaler 12GM pharmaceutical products. The $1,987.86 contract has a completion date of February 1, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. This delivery order is issued under a larger $999,999,999.00 indefinite delivery contract (IDC)...